The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Metformin as Anti-Aging Therapy: Is It for Everyone?
Open accessAbstract
Metformin is the most widely-prescribed oral hypoglycemic medication for type 2 diabetes worldwide. Metformin also retards aging in model organisms and reduces the incidence of aging-related diseases such as neurodegenerative disease and cancer in humans. In spite of its widespread use, the mechanisms by which metformin exerts favorable effects on aging remain largely unknown. Further, not all individuals prescribed metformin derive the same benefit, and some develop side effects. Before metformin finds its way to mainstay therapy for anti-aging, a more granular understanding of the effects of the drug in humans is needed. This review provides an overview of recent findings from metformin studies in aging and longevity and discusses the use of metformin to combat aging and aging-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“Metformin also has proven roles in prevention of diabetes [4], in treatment of polycystic ovary syndrome (PCOS) [5], and in helping individuals with diabetes prevent weight gain or even lose weight [6].”
BackgroundRole of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Kim, D.-H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 2,986
The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., et al. (2015) · Nature · doi:10.1038/nature15766 · Cited by 2,116
TOR, a Central Controller of Cell Growth
Schmelzle, T., & Hall, M. N. (2000) · Cell · doi:10.1016/s0092-8674(00)00117-3 · Cited by 1,924
Wu, H., Esteve, E., Tremaroli, V., Khan, M. T., Caesar, R., Mannerås-Holm, L., Ståhlman, M., Olsson, L. M., Serino, M., Planas-Fèlix, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4345 · Cited by 1,632
Metformin improves healthspan and lifespan in mice
Martin-Montalvo, A., Mercken, E. M., Mitchell, S. J., Palacios, H. H., Mote, P. L., Scheibye-Knudsen, M., Gomes, A. P., Ward, T. M., Minor, R. K., Blouin, M.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3192 · Cited by 1,445
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Regulation of TORC1 by Rag GTPases in nutrient response
Kim, E., Goraksha-Hicks, P., Li, L., Neufeld, T. P., & Guan, K.-L. (2008) · Nature Cell Biology · doi:10.1038/ncb1753 · Cited by 1,349
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284
Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
Lamming, D. W., Ye, L., Katajisto, P., Goncalves, M. D., Saitoh, M., Stevens, D. M., Davis, J. G., Salmon, A. B., Richardson, A., Ahima, R. S., et al. (2012) · Science · doi:10.1126/science.1215135 · Cited by 1,199
Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
Wheaton, W. W., Weinberg, S. E., Hamanaka, R. B., Soberanes, S., Sullivan, L. B., Anso, E., Glasauer, A., Dufour, E., Mutlu, G. M., Budigner, G. S., et al. (2014) · eLife · doi:10.7554/elife.02242 · Cited by 1,105
Metformin as a tool to target aging
Barzilai, N., Crandall, J. P., Kritchevsky, S. B., & Espeland, M. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.011 · Cited by 1,096 · cited 1×
“Metformin has been explored as an anti-aging agent in model organisms and humans [16,17], given its excellent safety record for over six decades in the clinic, well-documented beneficial properties in cardioprotection, and potential value in cancer prevention and treatment [18,19].”
BackgroundInfluence of TOR kinase on lifespan in C. elegans
Vellai, T., Takacs-Vellai, K., Zhang, Y., Kovacs, A. L., Orosz, L., & Müller, F. (2003) · Nature · doi:10.1038/426620a · Cited by 1,057
Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila Melanogaster
Bjedov, I., Toivonen, J. M., Kerr, F., Slack, C., Jacobson, J., Foley, A., & Partridge, L. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.11.010 · Cited by 1,057
Metformin: historical overview
Bailey, C. J. (2017) · Diabetologia · doi:10.1007/s00125-017-4318-z · Cited by 1,055
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Shu, Y., Sheardown, S. A., Brown, C., Owen, R. P., Zhang, S., Castro, R. A., Ianculescu, A. G., Yue, L., Lo, J. C., Burchard, E. G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30558 · Cited by 967
Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism
Cabreiro, F., Au, C., Leung, K.-Y., Vergara-Irigaray, N., Cochemé, H. M., Noori, T., Weinkove, D., Schuster, E., Greene, N. D. E., & Gems, D. (2013) · Cell · doi:10.1016/j.cell.2013.02.035 · Cited by 967
Amino acid signalling upstream of mTOR
Jewell, J. L., Russell, R. C., & Guan, K.-L. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3522 · Cited by 894
Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner
Kalender, A., Selvaraj, A., Kim, S. Y., Gulati, P., Brûlé, S., Viollet, B., Kemp, B. E., Bardeesy, N., Dennis, P., Schlager, J. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.014 · Cited by 889
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Miller, R. A., Chu, Q., Xie, J., Foretz, M., Viollet, B., & Birnbaum, M. J. (2013) · Nature · doi:10.1038/nature11808 · Cited by 833
Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK
Zhang, C.-S., Hawley, S. A., Zong, Y., Li, M., Wang, Z., Gray, A., Ma, T., Cui, J., Feng, J.-W., Zhu, M., et al. (2017) · Nature · doi:10.1038/nature23275 · Cited by 717
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Birsoy, K., Possemato, R., Lorbeer, F. K., Bayraktar, E. C., Thiru, P., Yucel, B., Wang, T., Chen, W. W., Clish, C. B., & Sabatini, D. M. (2014) · Nature · doi:10.1038/nature13110 · Cited by 710
de Jager, J., Kooy, A., Lehert, P., Wulffele, M. G., van der Kolk, J., Bets, D., Verburg, J., Donker, A. J. M., & Stehouwer, C. D. A. (2010) · BMJ · doi:10.1136/bmj.c2181 · Cited by 702
Onken, B., & Driscoll, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008758 · Cited by 671
Rheb promotes cell growth as a component of the insulin/TOR signalling network
Saucedo, L. J., Gao, X., Chiarelli, D. A., Li, L., Pan, D., & Edgar, B. A. (2003) · Nature Cell Biology · doi:10.1038/ncb996 · Cited by 658
TOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxO
Robida-Stubbs, S., Glover-Cutter, K., Lamming, D. W., Mizunuma, M., Narasimhan, S. D., Neumann-Haefelin, E., Sabatini, D. M., & Blackwell, T. K. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.007 · Cited by 648
McCartney, C. R., & Marshall, J. C. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1514916 · Cited by 581
Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study
Aroda, V. R., Edelstein, S. L., Goldberg, R. B., Knowler, W. C., Marcovina, S. M., Orchard, T. J., Bray, G. A., Schade, D. S., Temprosa, M. G., White, N. H., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3754 · Cited by 536
Campbell, J. M., Bellman, S. M., Stephenson, M. D., & Lisy., K. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.08.003 · Cited by 455
Metformin Action: Concentrations Matter
He, L., & Wondisford, F. E. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.003 · Cited by 448 · cited 2×
“Thus, it remains extremely plausible that mitochondrial effects of metformin dominate even at the micromolar levels obtainable in humans in vivo [43].”
BackgroundMetformin directly acts on mitochondria to alter cellular bioenergetics
Andrzejewski, S., Gravel, S.-P., Pollak, M., & St-Pierre, J. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-12 · Cited by 430
Metformin: Mechanisms in Human Obesity and Weight Loss
Yerevanian, A., & Soukas, A. A. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00335-3 · Cited by 414
Self-citationHowell, J. J., Hellberg, K., Turner, M., Talbott, G., Kolar, M. J., Ross, D. S., Hoxhaj, G., Saghatelian, A., Shaw, R. J., & Manning, B. D. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.009 · Cited by 408 · cited 1×
“Althoughmice genetically deficient in AMPK in liver respond normally to the antihyperglycemic effects of metformin, some work suggests that AMPK activation that occurs at therapeutically attainable metformin levels may be important for certain effects of biguanides [68,69].”
BackgroundBiguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling
Kickstein, E., Krauss, S., Thornhill, P., Rutschow, D., Zeller, R., Sharkey, J., Williamson, R., Fuchs, M., Köhler, A., Glossmann, H., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912793107 · Cited by 380
Justice, J. N., Ferrucci, L., Newman, A. B., Aroda, V. R., Bahnson, J. L., Divers, J., Espeland, M. A., Marcovina, S., Pollak, M. N., Kritchevsky, S. B., et al. (2018) · GeroScience · doi:10.1007/s11357-018-0042-y · Cited by 359
Bannister, C. A., Holden, S. E., Jenkins‐Jones, S., Morgan, C. L., Halcox, J. P., Schernthaner, G., Mukherjee, J., & Currie, C. J. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12354 · Cited by 356
Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2
De Haes, W., Frooninckx, L., Van Assche, R., Smolders, A., Depuydt, G., Billen, J., Braeckman, B. P., Schoofs, L., & Temmerman, L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321776111 · Cited by 355
Metformin slows down aging and extends life span of female SHR mice
Anisimov, V. N., Berstein, L. M., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Tyndyk, M. L., Yurova, M. V., Kovalenko, I. G., Poroshina, T. E., et al. (2008) · Cell Cycle · doi:10.4161/cc.7.17.6625 · Cited by 348
Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase
Hunter, R. W., Hughey, C. C., Lantier, L., Sundelin, E. I., Peggie, M., Zeqiraj, E., Sicheri, F., Jessen, N., Wasserman, D. H., & Sakamoto, K. (2018) · Nature Medicine · doi:10.1038/s41591-018-0159-7 · Cited by 313
Vitamin B12 Deficiency: Recognition and Management
Cyran, E. (2002) · Primary Care Case Reviews · doi:10.1097/00129300-200206000-00001 · Cited by 307
Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo
Madiraju, A. K., Qiu, Y., Perry, R. J., Rahimi, Y., Zhang, X.-M., Zhang, D., Camporez, J.-P. G., Cline, G. W., Butrico, G. M., Kemp, B. E., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0125-4 · Cited by 297
Anisimov, V. N., Berstein, L. M., Popovich, I. G., Zabezhinski, M. A., Egormin, P. A., Piskunova, T. S., Semenchenko, A. V., Tyndyk, M. L., Yurova, M. N., Kovalenko, I. G., et al. (2011) · Aging · doi:10.18632/aging.100273 · Cited by 285
Metformin activates AMPK through the lysosomal pathway
Zhang, C.-S., Li, M., Ma, T., Zong, Y., Cui, J., Feng, J.-W., Wu, Y.-Q., Lin, S.-Y., & Lin, S.-C. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.003 · Cited by 280
Metformin as an Anticancer Agent
Vancura, A., Bu, P., Bhagwat, M., Zeng, J., & Vancurova, I. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.07.006 · Cited by 274
Association of Biochemical B12 Deficiency With Metformin Therapy and Vitamin B12 Supplements
Reinstatler, L., Qi, Y. P., Williamson, R. S., Garn, J. V., & Oakley, G. P. (2012) · Diabetes Care · doi:10.2337/dc11-1582 · Cited by 265
Linking the Microbiota, Chronic Disease, and the Immune System
Hand, T. W., Vujkovic-Cvijin, I., Ridaura, V. K., & Belkaid, Y. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.08.003 · Cited by 247
The crucial impact of lysosomes in aging and longevity
Carmona-Gutierrez, D., Hughes, A. L., Madeo, F., & Ruckenstuhl, C. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.009 · Cited by 244
Vitamin B12 Deficiency: Recognition and Management.
Langan, R. C., & Goodbred, A. J. (2017) · PubMed · Cited by 243
Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults
Konopka, A. R., Laurin, J. L., Schoenberg, H. M., Reid, J. J., Castor, W. M., Wolff, C. A., Musci, R. V., Safairad, O. D., Linden, M. A., Biela, L. M., et al. (2019) · Aging Cell · doi:10.1111/acel.12880 · Cited by 238
A multiple kernel learning algorithm for drug-target interaction prediction
Nascimento, A. C. A., Prudêncio, R. B. C., & Costa, I. G. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-0890-3 · Cited by 235
An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. Elegans and Cancer
Wu, L., Zhou, B., Oshiro-Rapley, N., Li, M., Paulo, J. A., Webster, C. M., Mou, F., Kacergis, M. C., Talkowski, M. E., Carr, C. E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.055 · Cited by 227
Self-citationUsing C. elegans for aging research
Tissenbaum, H. A. (2015) · Invertebrate Reproduction & Development · doi:10.1080/07924259.2014.940470 · Cited by 222
Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK
Liu, X., Chhipa, R. R., Pooya, S., Wortman, M., Yachyshin, S., Chow, L. M. L., Kumar, A., Zhou, X., Sun, Y., Quinn, B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311121111 · Cited by 222
Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis
Griss, T., Vincent, E. E., Egnatchik, R., Chen, J., Ma, E. H., Faubert, B., Viollet, B., DeBerardinis, R. J., & Jones, R. G. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002309 · Cited by 213
Distinct perturbation of the translatome by the antidiabetic drug metformin
Larsson, O., Morita, M., Topisirovic, I., Alain, T., Blouin, M.-J., Pollak, M., & Sonenberg, N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201689109 · Cited by 205
Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice
Lee, H., Lee, Y., Kim, J., An, J., Lee, S., Kong, H., Song, Y., Lee, C.-K., & Kim, K. (2018) · Gut Microbes · doi:10.1080/19490976.2017.1405209 · Cited by 203
Metformin extends C. elegans lifespan through lysosomal pathway
Chen, J., Ou, Y., Li, Y., Hu, S., Shao, L.-W., & Liu, Y. (2017) · eLife · doi:10.7554/elife.31268 · Cited by 203
Slack, C., Foley, A., & Partridge, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047699 · Cited by 199
Epigenetic effects of metformin: from molecular mechanisms to clinical implications
Bridgeman, S. C., Ellison, G. C., Melton, P. E., Newsholme, P., & Mamotte, C. D. S. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13262 · Cited by 190
Kulkarni, A. S., Brutsaert, E. F., Anghel, V., Zhang, K., Bloomgarden, N., Pollak, M., Mar, J. C., Hawkins, M., Crandall, J. P., & Barzilai, N. (2018) · Aging Cell · doi:10.1111/acel.12723 · Cited by 183
Metformin: A Hopeful Promise in Aging Research
Novelle, M. G., Ali, A., Diéguez, C., Bernier, M., & de Cabo, R. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025932 · Cited by 178
Cao, J., Meng, S., Chang, E., Beckwith-Fickas, K., Xiong, L., Cole, R. N., Radovick, S., Wondisford, F. E., & He, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.567271 · Cited by 169
Johnson, J. A., Simpson, S. H., Toth, E. L., & Majumdar, S. R. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01448.x · Cited by 161
Thakur, S., Daley, B., Gaskins, K., Vasko, V. V., Boufraqech, M., Patel, D., Sourbier, C., Reece, J. M., Cheng, S.-Y., Kebebew, E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3167 · Cited by 159
Metformin Supplementation and Life Span in Fischer-344 Rats
Smith, D. L., Elam, C. F., Mattison, J. A., Lane, M. A., Roth, G. S., Ingram, D. K., & Allison, D. B. (2010) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glq033 · Cited by 153
Werner, E. A., & Bell, J. (1922) · Journal of the Chemical Society Transactions · doi:10.1039/ct9222101790 · Cited by 151
Lysosome-related Organelles as Mediators of Metal Homeostasis
Blaby, C., & Merchant, S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.592618 · Cited by 136
RNA polymerase III limits longevity downstream of TORC1
Filer, D., Thompson, M. A., Takhaveev, V., Dobson, A. J., Kotronaki, I., Green, J. W. M., Heinemann, M., Tullet, J. M. A., & Alic, N. (2017) · Nature · doi:10.1038/nature25007 · Cited by 130
Anisimov, V. N., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Тындык, М. Л., Egormin, P. A., Yurova, M. N., Rosenfeld, S. V., Semenchenko, A. V., Kovalenko, I. G., et al. (2010) · Aging · doi:10.18632/aging.100245 · Cited by 129
Metformin Is a Direct SIRT1-Activating Compound: Computational Modeling and Experimental Validation
Cuyàs, E., Verdura, S., Llorach-Parés, L., Fernández-Arroyo, S., Joven, J., Martin-Castillo, B., Bosch-Barrera, J., Brunet, J., Nonell-Canals, A., Sanchez-Martinez, M., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00657 · Cited by 122
Cellular Responses to the Metal-Binding Properties of Metformin
Logie, L., Harthill, J. E., Patel, K., Bacon, S., Hamilton, D. L., Macrae, K., McDougall, G. J., Wang, H., Xue, L., Jiang, H., et al. (2012) · Diabetes · doi:10.2337/db11-0961 · Cited by 116
The pharmacogenetics of metformin
Florez, J. C. (2017) · Diabetologia · doi:10.1007/s00125-017-4335-y · Cited by 102
Kane, D. A., Anderson, E. J., Price, J. W., Woodlief, T. L., Lin, C.-T., Bikman, B. T., Cortright, R. N., & Neufer, P. D. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.06.022 · Cited by 99
Metformin Decelerates Aging and Development of Mammary Tumors in HER-2/neu Transgenic Mice
Anisimov, V. N., Egormin, P. A., Берштейн, Л. М., Zabezhinskiĭ, M. A., Piskunova, T. S., Popovich, I. G., & Semenchenko, A. V. (2005) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-005-0389-9 · Cited by 99
Alshawi, A., & Agius, L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006670 · Cited by 88
Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
Argun, M., Üzüm, K., Sönmez, M. F., Özyurt, A., Karabulut, D., Soyersarica, Z., Çilenk, K. T., Ünalmış, S., Pamukçu, Ö., Baykan, A., et al. (2015) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2015.6185 · Cited by 86
Metformin directly targets the H3K27me3 demethylase KDM6A/UTX
Cuyàs, E., Verdura, S., Llorach-Parés, L., Fernández‐Arroyo, S., Luciano‐Mateo, F., Cabré, N., Štursa, J., Werner, L., Martín-Castillo, B., Viollet, B., et al. (2018) · Aging Cell · doi:10.1111/acel.12772 · Cited by 84
Control of Gluconeogenesis by Metformin: Does Redox Trump Energy Charge?
Baur, J. A., & Birnbaum, M. J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.013 · Cited by 73
Pyra, K. A., Saha, D. C., & Reimer, R. A. (2012) · Journal of Nutrition · doi:10.3945/jn.111.147132 · Cited by 73
Changes of Cell Biochemical States Are Revealed in Protein Homomeric Complex Dynamics
Stynen, B., Abd-Rabbo, D., Kowarzyk, J., Miller‐Fleming, L., Aulakh, S. K., Garneau, P., Ralser, M., & Michnick, S. W. (2018) · Cell · doi:10.1016/j.cell.2018.09.050 · Cited by 66
Pharmacokinetics of metformin in patients with gastrointestinal intolerance
MCCREIGHT, L. J., Stage, T. B., Connelly, P. J., Lonergan, M. E., Nielsen, F., Prehn, C. P., Adamski, J., Brøsen, K., & Pearson, E. R. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13264 · Cited by 59
Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes
Caesar, R. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.01.007 · Cited by 58
Which is the most significant cause of aging?
Liochev, S. (2015) · Antioxidants · doi:10.3390/antiox4040793 · Cited by 56
Twenty years of ovulation induction with metformin for PCOS; what is the best available evidence?
Hashim, H. A. (2015) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.09.015 · Cited by 54
Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases
Lanza, V., Milardi, D., Natale, G. D., & Pappalardo, G. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170518094404 · Cited by 53
Metformin-induced lactic acidosis: a case series
Silvestre, J., Carvalho, S., Mendes, V., Coelho, L., Tapadinhas, C., Ferreira, P., Póvoa, P. M. S. R., & Ceia, F. (2007) · Journal of Medical Case Reports · doi:10.1186/1752-1947-1-126 · Cited by 49
Metformin: Restraining Nucleocytoplasmic Shuttling to Fight Cancer and Aging
Castillo-Quan, J. I., & Blackwell, T. K. (2016) · Cell · doi:10.1016/j.cell.2016.11.058 · Cited by 45
Metformin reveals a mitochondrial copper addiction of mesenchymal cancer cells
Müller, S., Versini, A., Sindikubwabo, F., Belthier, G., Niyomchon, S., Pannequin, J., Grimaud, L., Cañeque, T., & Rodriguez, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206764 · Cited by 38
Kalantar‐Zadeh, K., & Kovesdy, C. P. (2016) · Diabetes Care · doi:10.2337/dc15-2327 · Cited by 37
Swindell, W. R. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw153 · Cited by 37
Bakris, G. L., & Molitch, M. E. (2016) · Diabetes Care · doi:10.2337/dc15-2534 · Cited by 32
Lactate Levels with Chronic Metformin Use: A Narrative Review
Huang, W., Castelino, R. L., & Peterson, G. M. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0564-6 · Cited by 27
The copper binding properties of metformin – QCM-D, XPS and nanobead agglomeration
Quan, X., Uddin, R., Heiskanen, A. R., Parmvi, M., Nilson, K., Donolato, M., Hansen, M. F., Rena, G., & Boisen, A. (2015) · Chemical Communications · doi:10.1039/c5cc04321b · Cited by 26
Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
Tseng, Y. (2016) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2016.18505 · Cited by 25
The lysosome among targets of metformin: new anti-inflammatory uses for an old drug?
Lockwood, T. D. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003774135 · Cited by 22
A Unique Case of Metformin-Associated Lactic Acidosis
Gershkovich, B., McCudden, C. R., & Burns, K. D. (2018) · Case Reports in Nephrology · doi:10.1155/2018/4696182 · Cited by 4
Cited by
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., & Li, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01251-0 · Cited by 1,718
Inflammation and aging: signaling pathways and intervention therapies
Li, X., Li, C., Zhang, W., Wang, Y., Qian, P., & Huang, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01502-8 · Cited by 1,443
Cellular senescence: the good, the bad and the unknown
Huang, W., Hickson, L. J., Eirin, A., Kirkland, J. L., & Lerman, L. O. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00601-z · Cited by 1,150
Benefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6
Tyrrell, D. J., & Goldstein, D. R. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0431-7 · Cited by 429
Metadata
- Authors
- Soukas, A. A., Hao, H., & Wu, L.
- Venue
- Trends in Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 30
- Issue
- 10
- Pages
- 745-755
- ISSN
- 1043-2760 (ISSN-L)
- OpenAlex
- W2968124120
- Cited by
- 263
- References
- 102
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.